Literature DB >> 11467857

Identification of human CPI-17, an inhibitory phosphoprotein for myosin phosphatase.

K Yamawaki1, M Ito, H Machida, N Moriki, R Okamoto, N Isaka, H Shimpo, A Kohda, K Okumura, D J Hartshorne, T Nakano.   

Abstract

CPI-17 is a phosphorylation-dependent inhibitor of myosin phosphatase. cDNA clones encoding CPI-17 were isolated from a human aorta library. Overlapping clones indicated two isoforms: CPI-17alpha was 147 residues and mass of 16.7 kDa; CPI-17beta (120 residues, mass 13.5 kDa) resulted from a deletion in the alpha-isoform of 27 residues, sequence 68-94. N-terminal 67 residues of all CPI-17 isoforms (human, porcine, rat and mouse) were highly conserved (for the human and porcine isoforms the identity was 91%). The presence of the two human isoforms was detected from cDNA sequences amplified by RT-PCR and by Western blots on human aorta. The cloned human CPI-17 gene indicated 4 coding exons and CPI-17beta was an alternative splice variant due to deletion of the second exon. FISH analysis located the human CPI-17 gene on chromosome 19q13.1. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11467857     DOI: 10.1006/bbrc.2001.5290

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Molecular characterization of myosin phosphatase in endothelium.

Authors:  Kyung-Mi Kim; Csilla Csortos; Istvan Czikora; David Fulton; Nagavedi S Umapathy; Gabor Olah; Alexander D Verin
Journal:  J Cell Physiol       Date:  2012-04       Impact factor: 6.384

Review 2.  Endogenous inhibitor proteins that connect Ser/Thr kinases and phosphatases in cell signaling.

Authors:  Masumi Eto; David L Brautigan
Journal:  IUBMB Life       Date:  2012-07-20       Impact factor: 3.885

3.  A bioinformatic and computational study of myosin phosphatase subunit diversity.

Authors:  Rachael P Dippold; Steven A Fisher
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-06-04       Impact factor: 3.619

4.  Cell culture retains contractile phenotype but epigenetically modulates cell-signaling proteins of excitation-contraction coupling in colon smooth muscle cells.

Authors:  Xuan-Zheng Shi; Sushil K Sarna
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-12-13       Impact factor: 4.052

5.  Differential signalling by muscarinic receptors in smooth muscle: m2-mediated inactivation of myosin light chain kinase via Gi3, Cdc42/Rac1 and p21-activated kinase 1 pathway, and m3-mediated MLC20 (20 kDa regulatory light chain of myosin II) phosphorylation via Rho-associated kinase/myosin phosphatase targeting subunit 1 and protein kinase C/CPI-17 pathway.

Authors:  Karnam S Murthy; Huiping Zhou; John R Grider; David L Brautigan; Masumi Eto; Gabriel M Makhlouf
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

6.  Putative protein partners for the human CPI-17 protein revealed by bacterial two-hybrid screening.

Authors:  Kyung-mi Kim; Djanybek M Adyshev; Anita Kása; Evgeny A Zemskov; Irina A Kolosova; Csilla Csortos; Alexander D Verin
Journal:  Microvasc Res       Date:  2013-04-12       Impact factor: 3.514

Review 7.  Regulation of cellular protein phosphatase-1 (PP1) by phosphorylation of the CPI-17 family, C-kinase-activated PP1 inhibitors.

Authors:  Masumi Eto
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

8.  Effect of KEPI (Ppp1r14c) deletion on morphine analgesia and tolerance in mice of different genetic backgrounds: when a knockout is near a relevant quantitative trait locus.

Authors:  J Drgonova; D B Zimonjic; F S Hall; G R Uhl
Journal:  Neuroscience       Date:  2009-10-09       Impact factor: 3.590

Review 9.  Myosin phosphatase: structure, regulation and function.

Authors:  Masaaki Ito; Takeshi Nakano; Ferenc Erdodi; David J Hartshorne
Journal:  Mol Cell Biochem       Date:  2004-04       Impact factor: 3.396

10.  Signaling through myosin light chain kinase in smooth muscles.

Authors:  Ning Gao; Jian Huang; Weiqi He; Minsheng Zhu; Kristine E Kamm; James T Stull
Journal:  J Biol Chem       Date:  2013-01-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.